KFDA to launch bio-equivalent test from Sept.

Published: 2001-08-07 07:00:00

Updated: 2001-08-07 07:00:00

The KFDA intends to proceed the bio-equivalent test projection from coming Sept. in order to facilitate a smooth implementation of the substituted dispensing practices at pharmacies.

Initially the KFDA elected 40 products to put an immediate test after adjusting opinions from the concerned dru...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK